Pseudoresistance to permethrin in scabies.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 05 2023
Historique:
received: 05 12 2022
accepted: 31 01 2023
medline: 8 6 2023
pubmed: 6 6 2023
entrez: 6 6 2023
Statut: epublish

Résumé

Reports of permethrin resistance of Sarcoptes scabiei var. hominis are emerging. We propose that this may be pseudoresistance. The resistance is due to inadequate counselling by physicians, incorrect treatment (insufficient quantity of permethrin; too short length of treatment), and poor adherence and compliance by patients. Other reasons include single application of permethrin, suggestion to apply the drug for 6-8 hours, failed application on subungual folds, irritant contact dermatitis, in particular on genitals, for which some patients stop the treatment, and unexplainable use of permethrin in post-scabies prurigo. Thus, we believe that several cases of resistance to permethrin are actually cases of pseudoresistance.

Identifiants

pubmed: 37279414
doi: 10.3855/jidc.17750
doi:

Substances chimiques

Permethrin 509F88P9SZ
Insecticides 0
Ivermectin 70288-86-7

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

713-715

Informations de copyright

Copyright (c) 2023 Stefano Veraldi, Rossana Schianchi, Martina Silvio, Italo Francesco Aromolo.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Stefano Veraldi (S)

Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Rossana Schianchi (R)

European Institute of Dermatology, Milan, Italy.

Martina Silvio (M)

Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Italo Francesco Aromolo (IF)

Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH